Company profile
VioQuest Pharmaceuticals, Inc.
OTC: VOQP · Healthcare · Biotechnology
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 40
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ 3-yr revenue growth, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$10.9M
Employees
3
as of 2026-08-29
Market cap
$14.7k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02007
Net income-$10.9M-$10.9M2007
Operating income$9.7M$9.7M2007
Total assets$1.4M$1.4M2007
Liabilities$5.8M$5.8M2007
Equity-$4.5M-$4.5M2007
Revenue trend
FY2000 – FY2007 · USD
FY00
FY01
FY02
FY03
FY04
FY05
FY06
FY07
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is VioQuest Pharmaceuticals, Inc.’s revenue?
VioQuest Pharmaceuticals, Inc. booked $0 in FY2007 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Healthcare Solutions Management Group, Inc.——Stem Cell Authority, Ltd.——ARYx Therapeutics, Inc.——Golden Developing Solutions, Inc.——CNBX Pharmaceuticals Inc.18DVaxxinity, Inc.——Neighbors
Somerset →Key facts
CEOMark D. Dacko
SectorHealthcare
IndustryBiotechnology
HeadquartersBasking Ridge, NJ
ExchangeOTC: VOQP
Employees3
IPO date1994-04-04
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.